Skip to content
DraconiticResearch
Search Sources API
182,544 studies31 sourcesUpdated 54 min ago
Peer-reviewedCC BYCJC open

Antiplatelet Therapy Strategies in Patients with High Bleeding Risk Treated with Complex Percutaneous Coronary Intervention: A Descriptive Study

  • Éloi Ravet-Claret1
  • Susan Chen1
  • Adèle Goulet1
  • Dan Tcaciuc1
  • Jamey Scraire1
  • Léa Turgeon-Mallette1
  • Marie Lordkipanidzé1
  • Marie-France Gauthier1
  • Julien Quang Le Van1
  1. 1Faculty of Pharmacy, Université de Montréal, Montreal, Quebec, Canada
Read full textPDFCite

Related

  1. Antiplatelet monotherapy maintenance strategies after percutaneous coronary intervention in patients with coronary artery disease at high bleeding risk: a network meta-analysis
    Xiao Zhang, YuJie Wang, YuXin Guo +1
    Frontiers in Cardiovascular MedicinePeer-reviewedCC BY 4.0Full textCardiovascular medicineCrossrefDOAJ
  2. Spontaneous Spinal Epidural Hematoma: An Urgent Complication of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention for Non-ST-elevation Myocardial Infarction
    Masashi Katagiri, Satoru Mitomo, Hiroto Yabushita +3
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaJ-STAGE
  3. Residual SYNTAX score and optical coherence tomography–derived thin-cap fibroatheroma in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention: an exploratory descriptive pilot study
    Meharunnisha Syed, Uma Devi Karuru, Sunitha Arumulla +3
    Journal of Cardiovascular ImagingPeer-reviewedCC BY 4.0Full textSurgery & anaesthesiaPMC
  4. How Short Is Safe? Duration of Dual Antiplatelet Therapy Before Aspirin Withdrawal After Percutaneous Coronary Intervention: A Dose-Response Network Meta-Analysis
    J.-S. Jang, K.-H. Kim, J. S. Park +2
    medRxivPreprintCC BY-NC-NDFull textCardiovascular medicinemedRxiv
  5. Dual antiplatelet therapy duration after percutaneous coronary intervention with contemporary drug-eluting stents: A systematic review and network meta-analysis of randomized trials
    Admire Hlupeni, Mehran Jalilzadehbinazar, Rayvlin J. Liceralde +3
    PLOS OnePeer-reviewedCC BY 4.0Full text1 citedStatisticsCardiovascular medicinePLOS

Cite

BibTeXRIS
BibTeX
@article{ravetclaret2026antiplatelet,
  title = {{Antiplatelet Therapy Strategies in Patients with High Bleeding Risk Treated with Complex Percutaneous Coronary Intervention: A Descriptive Study}},
  author = {Éloi Ravet-Claret and Susan Chen and Adèle Goulet and Dan Tcaciuc and Jamey Scraire and Léa Turgeon-Mallette and Marie Lordkipanidzé and Marie-France Gauthier and Julien Quang Le Van},
  journal = {CJC open},
  year = {2026},
  month = jul,
  url = {https://europepmc.org/article/PMC/PMC13654379},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Antiplatelet Therapy Strategies in Patients with High Bleeding Risk Treated with Complex Percutaneous Coronary Intervention: A Descriptive Study
AU  - Éloi Ravet-Claret
AU  - Susan Chen
AU  - Adèle Goulet
AU  - Dan Tcaciuc
AU  - Jamey Scraire
AU  - Léa Turgeon-Mallette
AU  - Marie Lordkipanidzé
AU  - Marie-France Gauthier
AU  - Julien Quang Le Van
PY  - 2026
DA  - 2026/07/01
JO  - CJC open
UR  - https://europepmc.org/article/PMC/PMC13654379
SN  - 2589-790X
ER  -